cell therapy product development

Developing a successful cell therapy product requires much more than demonstrating efficacy in the laboratory. The path from early research to clinical implementation involves a series of critical scientific, manufacturing, quality, regulatory, and strategic decisions that can significantly influence the likelihood of success.

This expert-led training workshop provides a practical overview of the complete cell therapy development journey, helping participants understand how individual development activities fit together and how early decisions can impact later stages of development.

Drawing on real-world industry experience, the workshop explores the key components of cell therapy product development, including process development, manufacturing strategy, analytical development, raw materials, quality systems, regulatory considerations, scalability, technology transfer, and clinical readiness.

Rather than focusing on theory alone, the workshop emphasizes practical lessons learned from the development of advanced therapy medicinal products (ATMPs), highlighting common challenges, frequent misconceptions, and development bottlenecks that can delay programs or increase risk.

Topics Covered
• The cell therapy development lifecycle: from concept to patient
• Product development strategy and critical decision points
• Process development and manufacturing considerations
• Raw materials and supply chain strategy
• Analytical development and product characterization
• Scalability and technology transfer
• Quality systems and GMP readiness
• Regulatory considerations and development planning
• Common pitfalls and lessons learned from industry programs

The workshop combines scientific, operational, and strategic perspectives to provide participants with a holistic understanding of what is required to successfully advance a cell therapy product toward clinical and commercial development.
‍
Intended Audience
This workshop is designed for organizations and teams involved in cell therapy and ATMP development, including research scientists, process development teams, CMC professionals, manufacturing specialists, quality personnel, regulatory affairs professionals, project managers, and business leaders seeking a broader understanding of the product development process.

It is particularly valuable for organizations entering the cell therapy field, building internal development capabilities, onboarding new team members, or seeking a common understanding of the end-to-end development journey.

Available as Corporate Training
This workshop is available as a customized training session for biotechnology companies, pharmaceutical organizations, CDMOs, academic groups, incubators, and innovation hubs.Sessions can be tailored to specific technologies, development stages, organizational objectives, and team sizes.

Certificate of Participation
Participants receive a Certificate of Participation issued by Nordic Cell Therapy Group upon completion of the workshop.

Interested in Hosting This Workshop?
Contact Nordic Cell Therapy Group to discuss customized delivery options for your organization or team.




‍